Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.

Source:http://linkedlifedata.com/resource/pubmed/id/20626389

Download in:

View as

General Info

PMID
20626389